captopril has been researched along with Malaria in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abreu, TP; Caruso-Neves, C; Dal-Cheri, BKA; Henriques, MG; Peruchetti, DB; Pinheiro, AAS; Silva, LS; Silva-Aguiar, RP; Souza, MC; Takiya, CM | 1 |
| Barros, NMT; Carmona, AK; Carvalho, CPF; Dantas, EO; Gazarini, ML; Martinez, C; Martins-Silva, L; Melo, PMS; Nagaoka, MR; Pesquero, JB; Ventura, PDS | 1 |
2 other study(ies) available for captopril and Malaria
| Article | Year |
|---|---|
The angiotensin II/AT1 receptor pathway mediates malaria-induced acute kidney injury.
Topics: Acute Kidney Injury; Angiotensin II; Angiotensin II Type 1 Receptor Blockers; Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Disease Models, Animal; Kidney; Losartan; Malaria; Male; Mice, Inbred C57BL; Plasmodium berghei; Random Allocation; Receptor, Angiotensin, Type 1 | 2018 |
Malaria infection promotes a selective expression of kinin receptors in murine liver.
Topics: Angiotensin-Converting Enzyme Inhibitors; Animals; Captopril; Chloroquine; Gene Expression Regulation; Liver; Malaria; Male; Mice; Mice, Inbred BALB C; Plasmodium chabaudi; Receptor, Bradykinin B1; Receptor, Bradykinin B2 | 2019 |